BRIDGEBIO PHARMA INC (BBIO) Stock Institutional Trading Activity
BRIDGEBIO PHARMA INC (BBIO) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Viking Global Investors, Polen Capital Management, and Renaissance Technologies LLC. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- BRIDGEBIO PHARMA INC (BBIO) stock institutional ownership
- BRIDGEBIO PHARMA INC (BBIO) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q4 2025 | Polen Capital Management | Buy | 2,077 | 38,241 | $2,925,054 |
| Q4 2025 | Viking Global Investors | Sell | -1,583,915 | 14,393,934 | $1,100,992,012 |
| Q3 2025 | Polen Capital Management | Buy | 515 | 36,164 | $1,878,358 |
| Q3 2025 | Renaissance Technologies LLC | Buy | 76,300 | 322,246 | $16,737,457 |
| Q3 2025 | Viking Global Investors | Sell | -2,577,526 | 15,977,849 | $829,889,477 |
| Q2 2025 | Polen Capital Management | Buy | 35,649 | 35,649 | $1,539,324 |
| Q2 2025 | Renaissance Technologies LLC | Sell | -338,200 | 245,946 | $10,619,948 |
| Q2 2025 | Viking Global Investors | Sell | -3,500,000 | 18,555,375 | $801,221,093 |
| Q1 2025 | Viking Global Investors | Sell | -3,065,616 | 22,055,375 | $762,454,314 |
| Q3 2023 | Renaissance Technologies LLC | Sell | -179,600 | 584,146 | $15,404 |
| Q3 2023 | Viking Global Investors | Sell | -1,500,000 | 25,120,991 | $662,440,533 |
| Q1 2023 | Renaissance Technologies LLC | Sell | -266,200 | 763,746 | $12,663 |
| Q4 2022 | Renaissance Technologies LLC | Sell | -336,800 | 1,029,946 | $7,848 |
| Q3 2022 | Renaissance Technologies LLC | Buy | 953,500 | 1,366,746 | $13,585 |
| Q2 2022 | Renaissance Technologies LLC | Buy | 294,700 | 413,246 | $3,752 |
| Q1 2021 | Renaissance Technologies LLC | Buy | 118,546 | 118,546 | $7,302 |
| Q2 2019 | Viking Global Investors | Buy | 26,620,991 | 26,620,991 | $717,968 |
Frequently asked questions about BBIO activity
Which institutional owners are buying BBIO?
Institutional owners buying BBIO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BBIO activity?
"Buy" means an investor increased their reported position in BBIO compared to the prior reporting period. This reflects growing exposure to BRIDGEBIO PHARMA INC (BBIO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BBIO increasing?
Institutional interest in BBIO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.